AlphaQuest LLC Increases Stock Position in Encompass Health Co. (NYSE:EHC)

AlphaQuest LLC grew its stake in Encompass Health Co. (NYSE:EHC) by 216.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 28,700 shares of the company’s stock after acquiring an additional 19,633 shares during the period. Encompass Health comprises 0.4% of AlphaQuest LLC’s investment portfolio, making the stock its 23rd biggest holding. AlphaQuest LLC’s holdings in Encompass Health were worth $2,650,000 as of its most recent filing with the SEC.

Other large investors have also recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB increased its holdings in Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after purchasing an additional 137 shares during the last quarter. Avior Wealth Management LLC purchased a new position in shares of Encompass Health during the third quarter worth $40,000. Tompkins Financial Corp acquired a new stake in shares of Encompass Health in the fourth quarter valued at $46,000. V Square Quantitative Management LLC raised its holdings in shares of Encompass Health by 43.8% in the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock valued at $54,000 after buying an additional 177 shares during the period. Finally, Morse Asset Management Inc acquired a new position in Encompass Health during the 3rd quarter worth about $68,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

EHC has been the subject of several research reports. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $110.00 target price on shares of Encompass Health in a research note on Tuesday, February 11th. Barclays raised their price target on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, February 7th. StockNews.com upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, February 15th. Finally, KeyCorp boosted their target price on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Monday, February 10th. Ten analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and an average price target of $107.67.

Encompass Health Stock Down 0.5 %

Shares of NYSE EHC opened at $99.20 on Friday. The business has a 50-day moving average of $96.95 and a two-hundred day moving average of $96.74. The company has a market capitalization of $9.99 billion, a price-to-earnings ratio of 22.24, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92. Encompass Health Co. has a 1 year low of $74.27 and a 1 year high of $104.55. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. On average, analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a dividend of $0.17 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 annualized dividend and a yield of 0.69%. Encompass Health’s dividend payout ratio is currently 15.25%.

Insider Activity at Encompass Health

In other news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares in the company, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.10% of the stock is owned by corporate insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.